Difference between revisions of "Part:BBa K1694013"
(8 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
<h1>'''Introduction:'''</h1> | <h1>'''Introduction:'''</h1> | ||
− | + | [[File:V21.png|200px|thumb|right|'''Fig.1''' OmpA-N-scFv (anti-VEGF)]] | |
− | To display the | + | To display the <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694003">scFv</a></html> outside the ''E. coli'', we used <html><a href="https://parts.igem.org/Part:BBa_K1694002"> Lipoprotein-Outer membrane protein A (Lpp-OmpA)</a></html>. According to the paper reference, we chose the first 9 amino acid of Lpp, and the 46~159 amino acid of OmpA. |
<br> | <br> | ||
− | In order to change | + | In order to easily change various scFv DNA sequence, we added a ''NcoI'' restriction site between OmpA and scFv. When designing XbaI-SpeI restriction site between Lpp-OmpA and scFv, it will cause a mixed site. Therefore, the ''NcoI'' restriction site rather than the EX-SP restriction site was designed. |
<br> | <br> | ||
− | The Fig.2 showed how we | + | The Fig.2 showed how we design Lpp-OmpA-N and scFv into ''NcoI'' restriction site. First, we digest Lpp-OmpA part with EcoRI and NcoI, scFv part with NcoI and PstI. Then we ligated them together. |
+ | |||
<br> | <br> | ||
<div style="display: block; height: 250pt;"> | <div style="display: block; height: 250pt;"> | ||
− | [[File:131415.png|600px|thumb|left|'''Fig.2''' The combination of | + | [[File:131415.png|600px|thumb|left|'''Fig.2''' The combination of OmpA-N-scFv]] |
− | [[File:ompascfv.png|250px|thumb|left|'''Fig.3''' | + | [[File:ompascfv.png|250px|thumb|left|'''Fig.3''' OmpA-N-scFv]] |
</div> | </div> | ||
+ | |||
+ | <html> | ||
+ | Introduction of basic parts: | ||
+ | <br> | ||
+ | |||
+ | <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694003"> Anti-VEGF </a><br> | ||
+ | </html> | ||
+ | |||
+ | |||
<h1>'''Experiment:'''</h1> | <h1>'''Experiment:'''</h1> | ||
− | [[File:OB.png|200px|thumb|left|'''Fig.4''' The PCR result of the Lpp-OmpA-N+scFv. The DNA | + | [[File:OB.png|200px|thumb|left|'''Fig.4''' The PCR result of the Lpp-OmpA-N+scFv. The length of DNA scquence is 1193 bp , so the PCR products should appear at 1200~1400 bp]] |
− | After receiving the DNA sequences from the gene synthesis company, we recombined each OmpA-N-scFv gene to | + | After receiving the DNA sequences from the gene synthesis company, we recombined each OmpA-N-scFv gene to pSB1C3 backbones and conducted a PCR experiment to check the size of each of the OmpA-N-scFv. The length of OmpA-N-scFv DNA scquence is 1193 bp. In this PCR experiment, the OmpA-N-scFv products size should be near at 1200~1400 bp. The Fig.4 showed the correct size of the OmpA-N-scFv, and proved that we successful ligated the scFv sequence onto an ideal backbone. |
− | [[File:OmpA-B.png|600px|thumb|center|'''Fig.5''' OmpA-N-scFv( | + | [[File:OmpA-B.png|600px|thumb|center|'''Fig.5''' OmpA-N-scFv (anti-VEGF)]] |
Latest revision as of 07:46, 22 September 2015
OmpA-scFv(Anti-VEGF)
Introduction:
To display the scFv outside the E. coli, we used Lipoprotein-Outer membrane protein A (Lpp-OmpA). According to the paper reference, we chose the first 9 amino acid of Lpp, and the 46~159 amino acid of OmpA.
In order to easily change various scFv DNA sequence, we added a NcoI restriction site between OmpA and scFv. When designing XbaI-SpeI restriction site between Lpp-OmpA and scFv, it will cause a mixed site. Therefore, the NcoI restriction site rather than the EX-SP restriction site was designed.
The Fig.2 showed how we design Lpp-OmpA-N and scFv into NcoI restriction site. First, we digest Lpp-OmpA part with EcoRI and NcoI, scFv part with NcoI and PstI. Then we ligated them together.
Introduction of basic parts:
Anti-VEGF
Experiment:
After receiving the DNA sequences from the gene synthesis company, we recombined each OmpA-N-scFv gene to pSB1C3 backbones and conducted a PCR experiment to check the size of each of the OmpA-N-scFv. The length of OmpA-N-scFv DNA scquence is 1193 bp. In this PCR experiment, the OmpA-N-scFv products size should be near at 1200~1400 bp. The Fig.4 showed the correct size of the OmpA-N-scFv, and proved that we successful ligated the scFv sequence onto an ideal backbone.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 388
- 1000COMPATIBLE WITH RFC[1000]